Institution
University of Cyprus
Education•Nicosia, Cyprus•
About: University of Cyprus is a education organization based out in Nicosia, Cyprus. It is known for research contribution in the topics: Large Hadron Collider & Standard Model. The organization has 3624 authors who have published 15157 publications receiving 412135 citations.
Topics: Large Hadron Collider, Standard Model, Lepton, Population, Quark
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this paper, a class of variable coefficient (1+1)-dimensional nonlinear reaction-diffusion equations of the general form f(x)ut=(g(x unux)x+h(x )um is investigated.
116 citations
••
TL;DR: Results indicated adequate psychometric characteristics for the Greek translation of the Brief-COPE for this population are indicated, and associations between coping strategies with gender, education, and psychological symptomatology are discussed.
Abstract: The construct of coping has received increasing attention over the past years in relation to psychological and physical health, yet its dimensional and conceptual understanding is not consistent across theoretical models. The present study investigates the dimensionality of coping in a sample of 1127 Greek-speaking adults using the Brief-COPE. Both exploratory and confirmatory factor analyses revealed a structure comprised of eight factors, four of which were broader, and included active/positive, avoidant, support seeking and negative emotional approaches. Results indicated adequate psychometric characteristics for the Greek translation of the Brief-COPE for this population. Associations between coping strategies with gender, education, and psychological symptomatology are also discussed.
116 citations
••
University of Belgrade1, Serbian Academy of Sciences and Arts2, Wrocław Medical University3, National and Kapodistrian University of Athens4, University of Cyprus5, Medical University of Vienna6, British Heart Foundation7, Pierre-and-Marie-Curie University8, Marmara University9, Karolinska University Hospital10, University of Perugia11, University of Brescia12, Hannover Medical School13, University Medical Center Groningen14, University of Hasselt15, The Volgograd State Medical University16, Queen's University Belfast17, National Institutes of Health18, Charité19, Vita-Salute San Raffaele University20
TL;DR: Type 2 diabetes mellitus is common in patients with heart failure (HF) and associated with considerable morbidity and mortality and there is evidence of several new glucose‐lowering medications showing either neutral or beneficial cardiovascular effects.
Abstract: Type 2 diabetes mellitus (T2DM) is common in patients with heart failure (HF) and associated with considerable morbidity and mortality. Significant advances have recently occurred in the treatment of T2DM, with evidence of several new glucose-lowering medications showing either neutral or beneficial cardiovascular effects. However, some of these agents have safety characteristics with strong practical implications in HF [i.e. dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1 RA), and sodium-glucose co-transporter type 2 (SGLT-2) inhibitors]. Regarding safety of DPP-4 inhibitors, saxagliptin is not recommended in HF because of a greater risk of HF hospitalisation. There is no compelling evidence of excess HF risk with the other DPP-4 inhibitors. GLP-1 RAs have an overall neutral effect on HF outcomes. However, a signal of harm suggested in two small trials of liraglutide in patients with reduced ejection fraction indicates that their role remains to be defined in established HF. SGLT-2 inhibitors (empagliflozin, canagliflozin and dapagliflozin) have shown a consistent reduction in the risk of HF hospitalisation regardless of baseline cardiovascular risk or history of HF. Accordingly, SGLT-2 inhibitors could be recommended to prevent HF hospitalisation in patients with T2DM and established cardiovascular disease or with multiple risk factors. The recently completed trial with dapagliflozin has shown a significant reduction in cardiovascular mortality and HF events in patients with HF and reduced ejection fraction, with or without T2DM. Several ongoing trials will assess whether the results observed with dapagliflozin could be extended to other SGLT-2 inhibitors in the treatment of HF, with either preserved or reduced ejection fraction, regardless of the presence of T2DM. This position paper aims to summarise relevant clinical trial evidence concerning the role and safety of new glucose-lowering therapies in patients with HF.
116 citations
••
TL;DR: This article applied quantitative genetics techniques to a sample of 851 pairs of monozygotic and 855 pairs of dizygotic female twins to examine the influence of genetic factors on the variation across people in opportunity recognition.
116 citations
••
TL;DR: Magnetization vs dc field sweeps on single-crystals of 3 displayed scan rate- and temperature-dependent hysteresis loops confirming that complex 3 is a new SMM, and is thus the second largest Mn cluster and SMM reported to date.
Abstract: The syntheses, crystal structures, and magnetic properties of a new family of heterometallic Mn40Na4 and homometallic Mn44 loop-of-loops aggregates are reported. The reactions of [Mn3O(O2CMe)6(py)3]·py with 1,3-propanediol (pdH2) and 2-methyl-1,3-propanediol (mpdH2) in the presence of NaN3 afforded [Mn10Na(μ3-O)2(O2CMe)13(pd)6(py)2]4 (1)4 and [Mn10Na(μ3-O)2(O2CMe)13(mpd)6(py)(H2O)]4 (2)4, respectively. Mn40Na4 complexes (1)4 and (2)4 consist of four Mn10 loops linked through Na+ ions to give a supramolecular aggregate with a saddle-like topology. Magnetic characterization of compound (1)4 showed that each Mn10 loop has an S = 4 ground-state spin and displays frequency-dependent in-phase and out-of-phase ac susceptibility signals. It also exhibits hysteresis loops that, however, are not typical of single-molecule magnets (SMMs) due to the existence of interloop interactions between the neighboring Mn10 units of (1)4 through the diamagnetic Na+ ions, and also intermolecular interactions between different Mn...
116 citations
Authors
Showing all 3715 results
Name | H-index | Papers | Citations |
---|---|---|---|
Luca Lista | 140 | 2044 | 110645 |
Peter Wittich | 139 | 1646 | 102731 |
Stefano Giagu | 139 | 1651 | 101569 |
Norbert Perrimon | 138 | 610 | 73505 |
Pierluigi Paolucci | 138 | 1965 | 105050 |
Kreso Kadija | 135 | 1270 | 95988 |
Daniel Thomas | 134 | 846 | 84224 |
Julia Thom | 132 | 1441 | 92288 |
Alberto Aloisio | 131 | 1356 | 87979 |
Panos A Razis | 130 | 1287 | 90704 |
Jehad Mousa | 130 | 1226 | 86564 |
Alexandros Attikis | 128 | 1136 | 77259 |
Fotios Ptochos | 128 | 1036 | 81425 |
Charalambos Nicolaou | 128 | 1152 | 83886 |
Halil Saka | 128 | 1137 | 77106 |